Cargando…
Myeloperoxidase: a new target for the treatment of stroke?
Myeloperoxidase is an important inflammatory factor in the myeloid system, primarily expressed in neutrophils and microglia. Myeloperoxidase and its active products participate in the occurrence and development of hemorrhagic and ischemic stroke, including damage to the blood-brain barrier and brain...
Autores principales: | Wang, Yun-Chang, Lu, Yu-Bao, Huang, Xiao-Lan, Lao, Yong-Feng, Zhang, Lu, Yang, Jun, Shi, Mei, Ma, Hai-Long, Pan, Ya-Wen, Zhang, Yi-Nian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820716/ https://www.ncbi.nlm.nih.gov/pubmed/35017418 http://dx.doi.org/10.4103/1673-5374.332130 |
Ejemplares similares
-
Plasma myeloperoxidase: association with atrial fibrillation progression and recurrence after catheter ablation
por: Liu, Jingmeng, et al.
Publicado: (2023) -
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
por: Koop, Anja Christina, et al.
Publicado: (2020) -
Myeloperoxidase: Regulation of Neutrophil Function and Target for Therapy
por: Rizo-Téllez, Salma A., et al.
Publicado: (2022) -
Association between myeloperoxidase rs2333227 polymorphism and susceptibility to coronary heart disease
por: Zhang, Yi-Qing, et al.
Publicado: (2020) -
Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles
por: Tong, Wei, et al.
Publicado: (2021)